Condition: Group 3 Pulmonary Hypertension · Sponsor: Foresee Pharmaceuticals Co., Ltd.
The goal of this clinical trial is to see if mirivadelgat will work in patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD). It will also learn about the safety of mirivadelgat. The main question it aims to answer is if mirivadelgat will improve pulmonary vascular resistance (PVR). Pulmonary vascular resistance is a way to measure blood flow in the lungs. Researchers will compare mirivadelgat to a placebo (a look-alike capsule that contains no drug) to see if mirivadelgat works to improve the symptoms of PH-ILD. The symptoms of PH-ILD that are being looked at are exercise tolerance, heart function, and general well-being. Participants will: Take mirivadelgat or a placebo once a day for 12 weeks Visit the clinic once every 4 weeks for checkups and tests Receive phone calls every one or two weeks to check on how things are going
This description comes directly from the study's public registry record.
Bassem Elmankabadi, MD · +1 562-310-8718 · Bassem.elmankabadi@foreseepharma.com
Yisheng Lee, MD · 408-823-4807 · yisheng.lee@foreseepharma.com
Always discuss trial participation with your own doctor first.
| Hualien Tzu Chi Hospital | Hualien City, Taiwan, Taiwan | Recruiting |
| Kaohsiung Medical University Chung-Ho Memorial Hospital | Kaohsiung City, Taiwan, Taiwan | Recruiting |
| Taichung Veterans General Hospital | Taichung, Taiwan, Taiwan | Recruiting |
| National Cheng Kung University Hospital | Tainan, Taiwan, Taiwan | Recruiting |
| National Taiwan University Hospital | Taipei, Taiwan, Taiwan | Recruiting |
| Taipei Veterans General Hospital | Taipei, Taiwan, Taiwan | Recruiting |
| Chang Gung Memorial Hospital - Linkou Branch | Taoyuan City, Taiwan, Taiwan | Recruiting |
| Kaohsiung Veterans General Hospital | Kaohsiung City, Taiwan | Recruiting |
| MacKay Memorial Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06475781